Want to join the conversation?
Biotechnology company $BIIB reported a 13% growth in 2Q16 earnings driven by revenue strength coupled with management of expenses as well as solid performance across its commercial business. Net income rose to $1.05Bil or $4.79 per share from $927MM or $3.93 per share last year. Non-GAAP EPS increased to $5.21 from $4.22.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?